Oxford Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5K | Buy |
+12,143
| New | +$37.5K | 0.01% | 484 |
|
|
2020
Q1 | – | Sell |
-22,051
| Closed | -$61K | – | 211 |
|
|
2019
Q4 | $61K | Buy |
+22,051
| New | +$61K | ﹤0.01% | 1658 |
|
|
2019
Q2 | – | Sell |
-71,560
| Closed | -$256K | – | 1663 |
|
|
2019
Q1 | $256K | Buy |
71,560
+29,517
| +70% | +$106K | 0.01% | 1443 |
|
|
2018
Q4 | $161K | Buy |
42,043
+10,305
| +32% | +$39.5K | ﹤0.01% | 1583 |
|
|
2018
Q3 | $302K | Sell |
31,738
-179,377
| -85% | -$1.71M | 0.01% | 1491 |
|
|
2018
Q2 | $1.54M | Sell |
211,115
-42,631
| -17% | -$311K | 0.03% | 815 |
|
|
2018
Q1 | $1.27M | Sell |
253,746
-88,007
| -26% | -$440K | 0.03% | 813 |
|
|
2017
Q4 | $1.74M | Buy |
341,753
+217,480
| +175% | +$1.11M | 0.04% | 648 |
|
|
2017
Q3 | $778K | Buy |
124,273
+40,963
| +49% | +$256K | 0.02% | 1050 |
|
|
2017
Q2 | $300K | Buy |
83,310
+39,436
| +90% | +$142K | 0.01% | 1258 |
|
|
2017
Q1 | $143K | Sell |
43,874
-116,312
| -73% | -$379K | ﹤0.01% | 1341 |
|
|
2016
Q4 | $392K | Buy |
+160,186
| New | +$392K | 0.01% | 624 |
|